Zenith poster from AACR EORTC meeting and Annual General/Special meeting date
|
4
|
Resverlogix Corp.
|
Nov 12, 2015 02:42PM
|
Re: Apabetalone downregulates factors and pathways associated with vascular calcification
|
4
|
Resverlogix Corp.
|
Nov 21, 2018 10:05AM
|
Re: Resverlogix & Zenith
|
4
|
Resverlogix Corp.
|
May 15, 2015 03:05PM
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
4
|
Resverlogix Corp.
|
Jan 19, 2016 04:07PM
|
Re: Notice of Meeting and Information Circular on SEDAR
|
4
|
Resverlogix Corp.
|
Aug 11, 2018 12:43PM
|
Zenith AGM is October 5, 2016
|
4
|
Zenith Epigenetics
|
Aug 07, 2016 10:47PM
|
Re: Bioasis nominated for the Buzz of BIO at the 2019 CEO & Investor Conference
|
4
|
BIOASIS TECHNOLOGIES INC
|
Dec 11, 2018 01:57PM
|
Re: Events section update...
|
4
|
Resverlogix Corp.
|
Jun 29, 2016 11:40AM
|
Near Final Draft of Checklist for Management
|
4
|
Resverlogix Corp.
|
Jul 26, 2016 04:18PM
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
4
|
Resverlogix Corp.
|
Dec 05, 2019 08:57PM
|
Re: 2 new upcoming presentations
|
4
|
Resverlogix Corp.
|
May 02, 2020 06:22PM
|
Zenith Epigenetics Advances ZEN-3694 in Multiple Cancer Programs
|
4
|
Zenith Epigenetics
|
Jul 29, 2020 09:59AM
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
4
|
Resverlogix Corp.
|
Jun 14, 2019 01:38PM
|
Re: ZEN-3694 mCRPC Trial Status
|
4
|
Zenith Epigenetics
|
Oct 26, 2017 12:57PM
|
Re: A couple Q2 events for Zenith
|
4
|
Zenith Epigenetics
|
May 11, 2017 10:58AM
|
Re: Another SGLT-2 inhibitor shows cardiovascular benefit in diabetics
|
4
|
Resverlogix Corp.
|
Jun 12, 2017 08:00PM
|
PNH Trial?
|
4
|
Resverlogix Corp.
|
Jun 30, 2017 12:59PM
|
Re: Top 5 things Apabetalone could correct for our health,...
|
4
|
Resverlogix Corp.
|
Nov 11, 2019 02:47PM
|
Re: 4-8b guess - Is someone asking too much?
|
4
|
Resverlogix Corp.
|
Dec 09, 2019 11:18AM
|
Yawn
|
4
|
Zenith Epigenetics
|
May 24, 2017 10:37AM
|